Sumimasa Nagai
- Co-authors
- Keiya OzawaMineo KurokawaAkira HangaishiZaina P. QureshiCharles L. BennettHiroyuki SatōKoji IzutsuKumi Oshima
- Topics
- Biomedical Ethics and Regulation (7 papers)Health Systems, Economic Evaluations, Quality of Life (5 papers)Pharmaceutical Economics and Policy (5 papers)
- Journals
- BloodOncogeneThe Lancet Oncology
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Sumimasa Nagai
25 papers receiving 194 citations
Peers
Comparison fields: 5 of 44
- Oncology 66
- Economics and Econometrics 59
- Immunology 45
- Molecular Biology 42
- Physiology 39
Countries citing papers authored by Sumimasa Nagai
This map shows the geographic impact of Sumimasa Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumimasa Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumimasa Nagai more than expected).
Fields of papers citing papers by Sumimasa Nagai
This network shows the impact of papers produced by Sumimasa Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumimasa Nagai. The network helps show where Sumimasa Nagai may publish in the future.
Co-authorship network of co-authors of Sumimasa Nagai
This figure shows the co-authorship network connecting the top 25 collaborators of Sumimasa Nagai. A scholar is included among the top collaborators of Sumimasa Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumimasa Nagai. Sumimasa Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 2 | |
| 10 | 7 | |
| 11 | 11 | |
| 12 | 27 | |
| 13 | 1 | |
| 14 | 10 | |
| 15 | 4 | |
| 16 | 6 | |
| 17 | 1 | |
| 18 | 2 | |
| 19 | 24 | |
| 20 | 24 |
About Sumimasa Nagai
Sumimasa Nagai is a scholar working on Oncology, Economics and Econometrics and Physiology, having authored 27 papers that have together received 196 indexed citations. Recurring topics across this work include Biomedical Ethics and Regulation (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical Economics and Policy (5 papers). The work is most often cited by research in Oncology (66 citations), Economics and Econometrics (59 citations) and Immunology (45 citations). Sumimasa Nagai has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Keiya Ozawa, Keiya Ozawa, Mineo Kurokawa, Akira Hangaishi, Zaina P. Qureshi, Charles L. Bennett, Hiroyuki Satō, Koji Izutsu, Kumi Oshima and Toru Motokura. Their work appears in journals such as Blood, Oncogene and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.